Eminence: Bio-Techne Announces Strategic Investment In Eminence
Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced an initial minority strategic equity investment in Changzhou Eminence Biotechnology Co., Ltd. ("Eminence").
Read full article »
Eminence is a biotechnology company that develops and commercializes Chinese Hamster Ovary cells for the pharmaceutical industry.
Read more